108 related articles for article (PubMed ID: 8347442)
1. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
Purcell H; Fox K
Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
[TBL] [Abstract][Full Text] [Related]
2. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
Specchia G; Marsico F; Micheletti T; Bona M
Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
[No Abstract] [Full Text] [Related]
3. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
Krumenacker M; Roland E
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of various ATP-sensitive potassium channel openers.
Grover GJ
Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
[No Abstract] [Full Text] [Related]
5. Nicorandil for angina.
Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
[TBL] [Abstract][Full Text] [Related]
6. Prescribing for angina.
Shetty K
Practitioner; 1994 Jul; 238(1540):540-2. PubMed ID: 7937508
[No Abstract] [Full Text] [Related]
7. [Therapeutic application of myocardial cytoprotection].
Ribeiro C
Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
[No Abstract] [Full Text] [Related]
8. [Anti-angina activity of potassium-channel activators].
Chiariello M; Duilio C; Ambrosio G
Cardiologia; 1993 Dec; 38(12 Suppl 1):459-63. PubMed ID: 8020048
[TBL] [Abstract][Full Text] [Related]
9. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Frampton J; Buckley MM; Fitton A
Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
[TBL] [Abstract][Full Text] [Related]
10. [K-channel activators and cardioprotection].
Specchia G; Marsico F; Laudisa ML
Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
[TBL] [Abstract][Full Text] [Related]
11. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Perrone Filardi P; Chiariello M
Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
[No Abstract] [Full Text] [Related]
12. [Increase of potassium conductance and spontaneous electric activity in vitro: comparison of nicorandil and cicletanine].
Dawodu AA; Schiariti M; Monti F; Lanti M; Giglio V; Terracciano CM; Puddu PE; Campa PP
Cardiologia; 1992 Feb; 37(2):141-9. PubMed ID: 1534710
[TBL] [Abstract][Full Text] [Related]
13. A symposium: A new treatment for angina pectoris and heart failure. October 17, 1987, San Francisco. Proceedings.
Am J Cardiol; 1989 Jun; 63(21):1J-85J. PubMed ID: 2525318
[No Abstract] [Full Text] [Related]
14. [Successful treatment of intraoperative myocardial ischemia with nicorandil].
Kawamura S; Hayashida M; Orii R; Sawamura S; Komatsu K; Ito N; Kuzumi E; Hanaoka K
Masui; 1997 Apr; 46(4):531-7. PubMed ID: 9128027
[TBL] [Abstract][Full Text] [Related]
15. [Nicorandil, a potassium channel agonist].
Gerson C
Soins; 1996 Nov; (610):61. PubMed ID: 9016185
[No Abstract] [Full Text] [Related]
16. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
Edwards RJ; Redwood SR; Lambiase PD; Marber MS
Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
[TBL] [Abstract][Full Text] [Related]
17. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
Cavero I; Premmereur J
Cardiovasc Res; 1994 Jan; 28(1):32-3. PubMed ID: 8111790
[No Abstract] [Full Text] [Related]
18. Evolving Issues in the Treatment of Angina Pectoris. Nicorandil: The 1st Potassium-Channel Activator in Ischemic Heart Disease. Proceedings of an International Workshop. Taormina, Sicily, May 8-12, 1991.
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-108. PubMed ID: 1282167
[No Abstract] [Full Text] [Related]
19. Potassium channel activators in vasospastic angina.
Lablanche JM; Bauters C; McFadden EP; Quandalle P; Bertrand ME
Eur Heart J; 1993 Jul; 14 Suppl B():22-4. PubMed ID: 8370368
[TBL] [Abstract][Full Text] [Related]
20. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
Critz SD; Liu GS; Chujo M; Downey JM
J Mol Cell Cardiol; 1997 Apr; 29(4):1123-30. PubMed ID: 9160864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
